Sort
261,768 grants matching “gene therapy”
Preparation and Distribution of Adult Stem Cells
$1,015,752Darwin Johnson Prockop · Texas A&M University Health Science Ctr · P40 · FY2008 · RR
Genome-Wide Discovery and Translational Research for Neural Repair
$1,015,652Stephen M Strittmatter · Yale University · R35 · FY2018 · NS
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
$1,015,591Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2021 · CA
Targeting mutant estrogen receptor driven breast cancers
$1,015,476Ganesh V Raj · Etirarx, Inc. · R44 · FY2022 · CA
Targeting intratumor heterogeneity in breast cancer
$1,015,451Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$1,015,368Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA
Phospholipid and Sphingolipid Signaling in Drosophila
$1,015,273Jairaj Acharya · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$1,015,160Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2018 · DC
Bio-Therapies for the Treatment of Cancer and Infectious Disease
$1,015,090David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
SPORE in Pancreatic Cancer
$1,015,068University Of Alabama At Birmingham · P20 · FY2005 · CA
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
$1,015,063Harold A Chapman · University Of California, San Francisco · U01 · FY2016 · HL
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer
$1,015,048A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2019 · CA
Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotic LR-IFN-β
$1,015,000Claude J. Rogers · Chromologic, Llc · R42 · FY2025 · AI
Neurogenetic Processes in the Fetal Brain
$1,014,758Pasko Rakic · Yale University · R01 · FY2011 · NS
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,014,721Pablo Tamayo · University Of California, San Diego · U01 · FY2018 · CA
Integrated Systems Biology Approach to Diabetic Microvascular Complications
$1,014,716Frank C Brosius · University Of Michigan At Ann Arbor · R24 · FY2010 · DK
Novel mechanisms of NSAID action in Alzheimer disease
$1,014,675University Of California San Diego · P01 · FY2003 · AG
Modified Ketogenic Diet Effects on Alzheimer's Disease Biomarkers and Cognition in Mild Cognitive Impairment
$1,014,666Suzanne Craft · Wake Forest University Health Sciences · R01 · FY2022 · AG
University of Pennsylvania (UPENN) Overall Coordinating & Clinical Trial Site
$1,014,652Caryn Lerman · University Of Pennsylvania · U01 · FY2012 · DA
GSK3b mediates convergence of protection signaling to limit mitochondrial damage
$1,014,645Steven Sollott · National Institute On Aging · ZIA · FY2015 · AG
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
$1,014,601Michael J Eck · Dana-Farber Cancer Inst · R35 · FY2024 · CA
The Colon Cancer Family Registry: Ontario
$1,014,593Steven Gallinger · Cancer Care Ontario · U24 · FY2008 · CA
Impact of Methamphetamine Use on the HIV Nucleome in Individuals on Antiretroviral Therapy
$1,014,569James Ivan Mullins · University Of Washington · R61 · FY2020 · DA
Tissue Processing-Sequencing Facility
$1,014,563Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
$1,014,535James A Decaprio · Dana-Farber Cancer Inst · R35 · FY2022 · CA